Prodromal Parkinsonian Features in GBA1 Mutation Carriers
Shaare Zedek Medical Center
600 participants
May 16, 2017
OBSERVATIONAL
Conditions
Summary
Objective of the trial. To define a sub-population which is at increased risk of developing Parkinson, beyond the fact of carrying Gaucher; in this sub-population the investigators shall conduct a comprehensive evaluation that includes a variety of non-invasive tests, whose purpose is to evaluate the state of the pre- Parkinson's disease signs, signs which can appear, even twenty years before the appearance of the disease, and also to compare them to a group of diagnosed Gaucher patients and a group of healthy people who are not carriers of Gaucher disease. A group of those carriers will be available for trial or for treatment, if there will be a medicine for the prevention of the development of Parkinson, obtainable.
Eligibility
Inclusion Criteria1
- Willing to participate
Exclusion Criteria2
- PD patients
- Dementia
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Tests to help identify prodromal PD in a cohort of carriers of Gaucher disease
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05253560